Ignite Creation Date:
2024-05-06 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03613168
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2018-07-28
Brief Title:
Trastuzumab in HER2-positive Biliary Tract Cancer
Sponsor:
Changhoon Yoo
Organization:
Asan Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-28
First Submit QC Date:
July 28 2018
Study First Post Date:
2018-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-04
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL